Skip to main content

Table 4 Optimization of GMP and PGH pellets

From: Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles

Batch Code % Drug content %CDR after 60 min
GMP PGH GMP PGH
B1 95.05 ± 2.11 93.42 ± 1.85 94.19 ± 3.64 95.28 ± 4.18
B2 95.22 ± 1.22 93.16 ± 2.31 94.05 ± 2.16 95.90 ± 3.25
B3 95.22 ± 2.05 93.01 ± 1.96 95.01 ± 2.35 94.81 ± 2.19
B4 94.30 ± 2.10 94.98 ± 2.61 93.69 ± 2.45 95.06 ± 2.05
B5 96.02 ± 2.60 95.23 ± 1.79 99.87 ± 1.96 98.13 ± 2.76
B6 94.25 ± 1.78 94.15 ± 1.50 95.11 ± 2.20 95.11 ± 2.20
B7 93.01 ± 1.21 94.90 ± 2.02 98.82 ± 1.14 97.51 ± 2.23
B8 92.12 ± 2.37 91.07 ± 2.08 93.12 ± 2.10 92.92 ± 3.81
B9 94.09 ± 1.77 95.93 ± 2.54 97.82 ± 2.47 94.05 ± 2.91
  1. Values are mean ± SD, n = 3